Therefore, these drugs do not modify PK activity sustained by PKM1 or other isoforms in cells expressing negligible or null amounts of PKM2 [33, 34], allowing us to assume that PKM1 could safeguard non-cancer cells. The gene discussed is PKM; the disease is cancer.